Table 1 Subject characteristics by treatment group at baseline.

From: Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans

 

Placebo

(n = 14)

G-PUR 2.0 g

(n = 14)

G-PUR 2 * 2.0 g (n = 14)

Age (years)

27 ± 5

27 ± 4

23 ± 2

Sex (m/f)

7/7

7/7

7/7

Body mass index (kg/m2)

21.5 ± 1.5

22.7 ± 2.3

22.6 ± 2.3

Haematocrit (%)

40.2 ± 2.7

41.7 ± 3.3

41.0 ± 2.2

Whole blood lead (μg/l)

16.2 ± 7.7

14.1 ± 10.0

14.8 ± 11.6

Plasma ferritin (µg/l)

75.3 ± 64.5

80.8 ± 52.3

82.0 ± 56.9

Plasma creatinine (mg/dl)

0.8 ± 0.1

0.8 ± 0.1

0.8 ± 0.2

  1. Absolute numbers and means ± SD are indicated.